Galactorrhea during escitalopram treatment: A case report;Essitalopram tedavisi sirasinda gelişen galaktore: Olgu sunumu

Klinik Psikofarmakoloji Bulteni

Volumn 16, Issue 1, 2006, Pages 39-41

  Gülsün, Murat ^a   Evrensel, Alper ^b   Verim, Samet ^a  

^a Asker Hastanesi   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Escitalopram; Galactorrhea; Panic disorder; Prolactin; Serotonin

Indexed keywords

ESCITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CASE REPORT; GALACTORRHEA; HUMAN; HYPERPROLACTINEMIA; PANIC;

EID: 33645542113     PISSN: 10177833     EISSN: 13029657     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Feuchtl A, Bagli M, Stephan R, Frahnert C, Kolsch H, Kuhn KU, Rao ML. Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile, Pharmacopsychiatry 2004;37:180-188
2. Meltzer H, Bastani B, Jayathilake K, Maes M. Fluoxetine, but not tricyclic antidepressants, potentiates the 5-Hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder. Neuropsychopharmacology 1997;17-21
3. Checkley S. Neuroendocrine effects of psychotropic drugs. Baillière's Clinical Endocrinology and Metabolism 1991;5;15-33
4. Wieck A, Haddad PM. Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Br J Psychiatry 2003;182:199-204
5. Bronzo MR, Stahl SM. Galactorrhea induced by sertraline (letter). Am J Psychiatry 1993;150:1269-1270
6. Hall MJ, Breast tenderness and enlargement induced by sertraline. Am J Psychiatry 1994;151:159
7. Peterson MC. Reversible galactorrhea and prolactin elevation related to fluoxetine use. Mayo Clin Proc 2001;76:215-216
8. Spigset O, Mjorndal T. The effect of fluvoxamine on serum prolactin and serum sodium concentrations: relation to platelet 5-HT2A receptor status. J Clin Psychopharmacol 1997;17:292-297
9. Nadeem HS, Attenburrow MJ, Cowen PJ. Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses. Neuropsychopharmacology 2004;29:1699-1703
10. Çorapçioǧlu A, Aydemir Ö, Yildiz M, Esen A, Köroǧlu E. DSM-IV Eksen I Bozukluklari (SCID-I) için Yapilandirilmiş Klinik Görüşme, Klinik Versiyon. Ankara: Hekimler Yayin Birliǧi, 1999
11. Reichlin S. Neuroendocrinology. In:Wilson JD, Foster DW, eds. Textbook of endocrinology, 7th ed. Philladelphia: Saunders, 1985:492-567
12. Cooper DS, Gelenberg AJ, Wojcik JC, Saxe VC, Ridgway C, Maloof F. The effect of amoxapine and imipramine on serum prolactin levels. Ann Intern Med 1981;141:1023-1025
13. Golden RN, Ruegg R, Brown TW, Haggerty J, Garbutt JC, Pedersen CA, Evans DL. Abnormal neuroendocrine responsivity to clomipramine in depression. Psychopharmacol Bull 1990;26:317-320
14. Jorgensen H, Knigge U, Warberg J. Involvement of the 5-HT1, 5-HT2 and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5 hydroxytryptophan. Neuroendocrinology 1992;55:336-343
15. Lowy MT, Meltzer HY. Stimulation of serum cortizol and prolactin secretion in humans by MK-212, a centrally active serotonin agonist. Biol Psychiatry 1988;23:818-828
16. Coccaro EF, Kavouss, RJ, Oakes M, Cooper TB, Hauger R. 5-HT2A receptor blockade by amsergide fully attenuates prolactin response to d-fenfluramine in physically healty subjects. Psychopharmacology 1996;126:24-30